Tonix Pharmaceuticals Holding (TNXP) Change in Cash (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Change in Cash for 17 years, with the latest figure at -$9.4 million in Q2 2026.

• On a quarterly basis, Change in Cash fell 47.09% year-over-year to -$9.4 million in Q2 2026; TTM through Jun 2026 was $50.4 million, a 58.42% decrease from a year earlier, with the FY2025 full-year figure at $110.1 million, up 49.16% from the prior year.
• Change in Cash was -$9.4 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from -$23.8 million in the prior quarter.
• The five-year high for Change in Cash was $70.5 million in Q4 2024, with the low at -$48.3 million in Q1 2023.
• Average Change in Cash over 5 years is -$126722.2, with a median of -$7.9 million recorded in 2025.
• The largest YoY upside for Change in Cash was 2328.11% in 2022 against a maximum downside of 358.19% in 2022.
• Over 5 years, Change in Cash stood at -$19.7 million in 2022, then soared by 190.81% to $17.9 million in 2023, then surged by 293.38% to $70.5 million in 2024, then sank by 73.84% to $18.5 million in 2025, then slumped by 150.87% to -$9.4 million in 2026.
• The last three Change in Cash figures came in at -$9.4 million (Q2 2026), -$23.8 million (Q1 2026), and $18.5 million (Q4 2025), per Business Quant data.